Physician profile
Danielle M Demeter
NPI 1265447940
$728.45
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $287 · 2022: $214 · 2023: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $227.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $451.62 | 2021-2023 | |
| Abbvie INC. | $71.37 | 2022 | |
| Kaleo, INC. | $52.40 | 2021-2022 | |
| Allergan, INC. | $26.31 | 2022 | |
| Alkermes, INC. | $19.78 | 2023 | Vivitrol |
| Ultragenyx Pharmaceutical INC. | $18.82 | 2022 | |
| Galderma Laboratories, L.P. | $17.61 | 2021 | |
| Dynavax Technologies Corporation | $16.63 | 2022 | |
| Idorsia Pharmaceuticals US INC | $15.56 | 2023 | Quviviq |
| Lucid Diagnostics INC. | $13.55 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.54 | 2022 | |
| Genentech USA, INC. | $12.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Demeter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.